miRNA单核苷酸多态性与HBV感染相关疾病关系的研究进展

doi:10.13481/j.1671-587X.20210633

Abstract

CLC Number:

R512.62

References 44

1	YUEN M F， CHEN D S， DUSHEIKO G M， et al. Hepatitis B virus infection［J］.Nat Rev Dis Primers， 2018， 4： 18035.
2	SUNG H， FERLAY J， SIEGEL R L， et al. Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA A Cancer J Clin， 2021， 71（3）： 209-249.
3	TANG L S Y， COVERT E， WILSON E，et al. Chronic hepatitis B infection： a review［J］.JAMA，2018，319（17）： 1802-1813.
4	SARTORIUS， MAKAROVA， SARTORIUS， et al. The regulatory role of MicroRNA in hepatitis-B virus-associated hepatocellular carcinoma （HBV-HCC） pathogenesis［J］. Cells， 2019， 8（12）： 1504.
5	SUGIYAMA M， INUI A， SHIN-I T， et al. Easy-to-use phylogenetic analysis system for hepatitis B virus infection［J］. Hepatol Res， 2011， 41（10）： 936-945.
6	XU Y M， LI L W， XIANG X G， et al. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma： a systematic review and meta-analysis［J］. Gene， 2013， 527（2）： 584-593.
7	KETTING R F. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans［J］. Genes Dev， 2001， 15（20）： 2654-2659.
8	KRÓLICZEWSKI J， SOBOLEWSKA A， LEJNOWSKI D，et al. microRNA single polynucleotide polymorphism influences on microRNA biogenesis and mRNA target specificity［J］. Gene， 2018， 640： 66-72.
9	LI X， GIBSON G， KIM J S，et al.MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis［J］. Gene， 2011， 480（1/2）： 34-41.
10	HOU Z H， HAN Q J， ZHANG C， et al.miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes［J］. Liver Int， 2014， 34（1）： 58-68.
11	WANG Y， LI Y. miR-146 promotes HBV replication and expression by targeting ZEB2［J］.Biomed Pharmacother， 2018， 99： 576-582.
12	FU L， FU X， MO J， et al.miR-146a-5p enhances hepatitis B virus replication through autophagy to promote aggravation of chronic hepatitis B［J］. IUBMB Life， 2019， 71（9）： 1336-1346.
13	HOU Z， ZHANG J， HAN Q， et al. Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a［J］. Sci Rep， 2016， 6： 26150.
14	DAI Z J， SHAO Y P， WANG X J，et al. Five common functional polymorphisms in microRNAs （rs2910164， rs2292832， rs11614913， rs3746444， rs895819） and the susceptibility to breast cancer： evidence from 8361 cancer cases and 8504 controls［J］. Curr Pharm Des， 2015， 21（11）： 1455-1463.
15	XIE W Q， WANG X F.MiR-146a rs2910164 polymorphism increases the risk of digestive system cancer： a meta-analysis［J］.Clin Res Hepatol Gastroenterol， 2017， 41（1）： 93-102.
16	ZHANG L H， ZHANG C Y， DAI X Z，et al. Association between miR-146a single nucleotide polymorphism and genetic susceptibility to hepatocellular carcinoma： a meta-analysis［J］. Zhonghua Gan Zang Bing Za Zhi， 2017， 25（10）： 749-754.
17	JIANG H J， HE X X， LI J， et al. Association of a single-nucleotide polymorphism within the miR-146a gene with susceptibility for acute-on-chronic hepatitis B liver failure［J］. Immunogenetics， 2013，65（4）： 257-263.
18	KHANIZADEH S， HASANVAND B， NIKOO H R， et al.Association between miRNA-146a rs2910164 （G/C） polymorphism with the susceptibility to chronic HBV infection and spontaneous viral clearance in an Iranian population［J］. J Med Virol， 2019， 91（6）：1063-1068.
19	AL-QAHTANI A A， AL-ANAZI M R， NAZIR N，et al.Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications： a study in a Saudi Arabian population［J］. J Viral Hepat， 2017，24（12）： 1132-1142.
20	WU C Y， TANG G， WANG X Y，et al. Micro-RNA-21 rs1292037 A>G polymorphism can predict hepatocellular carcinoma prognosis （HCC）， and plays a key role in cell proliferation and ischemia-reperfusion injury （IRI） in HCC cell model of IRI［J］. Saudi Med J， 2020， 41（4）： 383-392.
21	LIN Y， DENG W Y， PANG J K，et al. The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy［J］. Cell Microbiol， 2017， 19（5）： e12709.
22	LAMPROPOULOU D I， ARAVANTINOS G， LASCHOS K，et al. MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer［J］.Int J Colorectal Dis，2019，34（11）：1871-1877.
23	MOTAWI T K， MADY A E， SHAHEEN S，et al. Genetic variation in microRNA-100（miR-100） rs1834306 T/C associated with Hepatitis B virus （HBV） infection： Correlation with expression level［J］. Infect Genet Evol， 2019， 73： 444-449.
24	QIAO C X， YANG L L， WAN J E，et al. Long noncoding RNA ANRIL contributes to the development of ulcerative colitis by miR-323b-5p/TLR4/MyD88/NF-κB pathway［J］. Biochem Biophys Res Commun， 2019， 508（1）： 217-224.
25	SONG L P， LIU H， GAO S J，et al. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells［J］.J Virol，2010，84（17）：8849-8860.
26	YU S J， KIM J W， LEE J H， et al. Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication［J］. J Viral Hepat， 2014， 21（12）： 853-859.
27	CHEONG J Y， SHIN H D， CHO S W，et al. Association of polymorphism in MicroRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma［J］. J Korean Med Sci， 2014， 29（11）： 1523-1527.
28	CHEONG J Y， SHIN H D， KIM Y J，et al. Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection［J］.J Med Virol，2013， 85（5）： 808-814.
29	徐京杭，徐小元，于岩岩.不确定期慢性HBV感染者可能获益于抗病毒治疗［J］.临床肝胆病杂志，2021，37（11）：2539-2540.
30	QI P， DOU T H， GENG L， et al.Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection［J］. Hum Immunol， 2010， 71（6）： 621-626.
31	ZHANG Q， SU J， WANG Z， et al. MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway［J］. Oncotarget， 2017， 8（39）： 65397-65406.
32	LUO G， CHAO Y L， TANG B， et al.miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F［J］. Oncotarget， 2015， 6（35）： 37808-37823.
33	LIU M F， CHEN W Q， HE Y Z， et al. Role of miR-149C>T polymorphisms on the risk of hepatocellular carcinoma in a Chinese population［J］. Genet Mol Res， 2014， 13（3）： 7184-7189.
34	WANG R， ZHANG J， MA Y Y， et al.Association study of miR‑149 rs2292832 and miR‑608 rs4919510 and the risk of hepatocellular carcinoma in a large‑scale population［J］. Mol Med Rep， 2014， 10（5）： 2736-2744.
35	PRATEDRAT P， SOPIPONG W， MAKKOCH J，et al.Single nucleotide polymorphisms in miR-149 （rs2292832） and miR-101-1 （rs7536540） are not associated with hepatocellular carcinoma in Thai patients with hepatitis B virus infection［J］. Asian Pac J Cancer Prev， 2015， 16（15）： 6457-6461.
36	ZOU H Z， ZHAO Y Q. Positive association between miR-499 A>G and hepatocellular carcinoma risk in a Chinese population［J］. Asian Pac J Cancer Prev， 2013， 14（3）： 1769-1772.
37	XIANG Y， FAN S， CAO J， et al. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population［J］. Mol Biol Rep， 2012， 39（6）： 7019-7023.
38	LI X H， LI K， WU Z J. Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma［J］. Int J Clin Exp Pathol， 2015， 8（8）： 9560-9566.
39	KIM W H， MIN K T， JEON Y J， et al. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population［J］.Gene，2012，504（1）：92-97.
40	FAROKHIZADEH Z， DEHBIDI S， GERAMIZADEH B，et al. Association of MicroRNA polymorphisms with hepatocellular carcinoma in an Iranian population［J］. Ann Lab Med， 2019， 39（1）： 58-66.
41	WANG B G， JIANG L Y， XU Q. Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk： a systematic review and meta-analysis［J］. Biosci Rep， 2018， 38（5）：BSR20180712.
42	YIN X， SUN S， ZHAO J， et al. Rs4705342 polymorphism is involved in the tumorigenesis of HBV positive HCC by altering the binding affinity of HBV induced NF-kB with the promoter region of microRNA-143［J］. J Cell Biochem， 2018， 119（7）： 5233-5242.
43	张冬青，郑瑞丹，林明华，等.HBV相关慢加急性肝衰竭患者90天预后影响因素分析［J］.临床肝胆病杂志，2021，37（10）：2316-2319.
44	文夏杰，李桂馨，李婕，等.合并非酒精性脂肪性肝病的慢性乙型肝炎患者HBV复制与脂代谢的相互影响［J］.临床肝胆病杂志，2021，37（7）：1495-1500.

[1]	LIN Xiaoe, WU Jinghua, LI Jie, LIU Yang, SHEN Xiaonan, ZHU Chaoqian, LI Guangping. Detection of expression levels of miR-194-5p and MagT1 in peripheral blood mononuclear cells of patients with chronic HBV infection and their significances [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 607-613.
[2]	GAO Peng, LUO Yanping, LI Junfeng. Effects of hepatitis B virus on T lymphocytes and their subsets in chronic hepatitis B patients in different ALT states [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 359-364.
[3]	ZHONG Zhefeng, XIE Jingjing, HE Jian, JIANG Bo, LYU Jian. Enhancement effect of magnesium-L-threonate for antiviral effect of entecavir in HBV-infected mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 260-265.
[4]	LEI Xiaoyan, SUN Yonghong, CHEN Xingxing, GAO Xia, SONG Yuanchun, SAI Yipa, LIU Jing, YUAN Hong. Detection of HBV-cccDNA level in children with hepatitis B virus associated glomerulonephritis and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2018, 44(06): 1256-1262.
[5]	KE Haijin, CHEN Xiaoyan, GUO Yong, LUO Lihui, WU Jieling. Analysis of positive rate of sIgE for common allergens in infants with cow'smilk protein allergy [J]. Journal of Jilin University Medicine Edition, 2018, 44(02): 363-367.
[6]	CHANG Caifang, HOU Yong, CONG Gang. Therapeutic effect of α-2b interferon on inflammation of liver tissue and liver fibrosis in hepatitis B model ducks [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 11-15.
[7]	WEI Yanhong, SONG Shuai, GENG Hui, DIAO Binbin, YANG Guangmin. Clinical significance of detection of alpha 1-microglobulin in serum of patients with chronic hepatitis B [J]. Journal of Jilin University Medicine Edition, 2017, 43(01): 96-100.
[8]	YANG Zhi，CHEN Hong-tao，ZHANG Yi，WU Shi-pin. Expressions of T-bet,GATA3 and FoxP3 mRNA in PBMCs in patients with chronic hepatitis B virus infectionand their significances [J]. Journal of Jilin University Medicine Edition, 2013, 39(5): 953-959.
[9]	MA Li, ZHANG Wei, XU Gang-zhu,YAO Yang, XU Li, LIU Kai-ge. Expressions of HBx and CEACAM1 in HBV-related hepatocellular carcinoma and their significances [J]. J4, 2012, 38(4): 779-783.
[10]	ZENG Zhi-li,WU Jian-lin,WU Ji-zhou. Detection of proportions \|of lymphocyte T subsets in peripheral blood and levels of \|Th1/Th2 \|cytokines in patients with hepatitis B virus infection and its clinical significance [J]. J4, 2012, 38(3): 555-558.
[11]	LIU Yuan-Yuan, MA Zhen-Hua, NIU Jun-Qi, JIANG Yan-Fang. Changes of HBV P gene RT region mutation model and  drug-resistant rate in patients with chronic hepatitis B treated with telbivudime for different time [J]. J4, 2010, 36(4): 691-694.
[12]	Liu-Jing-Jing, LIU Yuan-Yuan, LIU Yong-Hua, WANG Feng, JIANG Yan-Fang. Changes of HBV P gene RT region mutation model and \|drug-resistant rate in patients with chronic hepatitis B treated with telbivudime for different time [J]. J4, 2010, 36(4): 695-697.
[13]	ZHANG Man-Li, GAO Pu-Jun, GAO Run-Ping. Detection of serum TGF-β1,CTGF and Col Ⅰ levels in patients with hepatitis B virus-induced chronic liver diseases and its significances [J]. J4, 2010, 36(1): 150-153.
[14]	. Evalution of curative effect of adefovir in treatment of Hep B cirrhosis [J]. J4, 2010, 36(1): 175-177.
[15]	LIU Yuan-Yuan, MA Zhen-Hua, PIAO Rong-Li, NIU Jun-Qi. Changes of Th1/Th2 cytokines levels in serum in patients with \|chronic hepatitis B before and after treatment of thymosin [J]. J4, 2009, 35(6): 1107-1110.

Reasearch progress in relationships between miRNA single nucleotide polymorphisms and HBV infection-related diseases

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 44

Related Articles 15

Metrics

Comments

Recommended 10